Méningoencéphalites d’origine inconnue chez le chien (notice n° 762491)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 04031cam a2200553 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250123102947.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Vandenberghe, Hélène |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Méningoencéphalites d’origine inconnue chez le chien |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2022.<br/> |
500 ## - GENERAL NOTE | |
General note | 81 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Meningoencephalitides of unknown origin are common inflammatory conditions of the canine central nervous system. They result from an aberrant immune response targeting the brain and/or sometimes the spinal cord. Diagnosis is based on epidemiology, clinical signs, abnormalities on MRI and/or cerebrospinal fluid analysis and exclusion of infectious agents causing encephalitis in dogs. The treatment is immunosuppression and primarily based on steroids. Other immunosuppressive agents have been used, primarily allowing reduction of steroid-associated side effects. Their influence on prognosis isn’t supported by evidence. The follow up is mostly based on monitoring clinical signs although repeating the MRI scan and cerebrospinal fluid analysis prior to tapering the treatment might help reduce the risk of relapse. The prognosis varies widely between cases and depends on clinical signs and neuroanatomical localization of the lesions. The dogs improving on medication and surviving beyond three months are less likely to die because of the disease. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Les méningoencéphalites d’origine indéterminée sont des maladies inflammatoires fréquentes du système nerveux central chez le chien. Elles sont la conséquence d’une réponse à médiation immune aberrante dirigée contre l’encéphale et/ou parfois la moelle spinale. Un diagnostic présomptif peut être établi sur la base d’une combinaison de critères épidémiologiques et cliniques, d’anomalies typiques à l’examen IRM du système nerveux central et/ou à l’analyse du liquide cérébrospinal et de l’exclusion des agents infectieux responsables d’encéphalite. Le traitement est immunosuppresseur, basé prioritairement sur la corticothérapie. L’utilisation d’autres agents immunosuppresseurs, dont le principal bénéfice est de limiter les effets secondaires liés à la corticothérapie a été décrite, sans que leur impact sur le pronostic n’ait été démontré pour l’heure. Le suivi est avant tout clinique, bien qu’une répétition de l’examen IRM et de l’analyse du liquide cérébrospinal avant diminution du traitement puisse contribuer à limiter le risque de rechute. Le pronostic est extrêmement variable et fonction des signes cliniques et de la localisation des lésions. Les animaux s’améliorant sous traitement et survivant plus de trois mois, décèdent rarement de la maladie. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | corticothérapie |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | auto-immunité |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | liquide cérébrospinal |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | méningite |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | chien |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | encéphalite |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | cytosine arabinoside |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | imagerie par résonance magnétique |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | corticothérapie |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | auto-immunité |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | liquide cérébrospinal |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | méningite |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | chien |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | encéphalite |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | cytosine arabinoside |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | imagerie par résonance magnétique |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | meningitis |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | steroids |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | magnetic resonance imaging |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | encephalitis |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | cerebrospinal fluid |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | dog |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | cytosine arabinoside |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | immune-mediated |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | meningitis |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | steroids |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | magnetic resonance imaging |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | encephalitis |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | cerebrospinal fluid |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | dog |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | cytosine arabinoside |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | immune-mediated |
786 0# - DATA SOURCE ENTRY | |
Note | Le Nouveau Praticien Vétérinaire - Canine & féline | 19 | HS1 | 2022-12-11 | p. 92-100 | 1637-3065 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-le-nouveau-praticien-veterinaire-canine-et-feline-2022-HS1-page-92?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-le-nouveau-praticien-veterinaire-canine-et-feline-2022-HS1-page-92?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux